We are two cofounders that have financed the creation and prototyping of our two platforms and now have a first migraine platform ready to launch.
We are in discussions with a major hospital organization and four pharmaceutical companies regarding strategic partnerships targeting clinical trials, further product development, obtaining access to data for educating our AI, and joint commercialization of our platforms.